Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Juvenile dermatomyositis].

F Dressler1, H-I Huppertz

  • 1Kinderklinik der Medizinischen Hochschule, 30623 Hannover. dressler.frank@mh-hannover.de

Zeitschrift Fur Rheumatologie
|October 20, 2006
PubMed
Summary

Juvenile dermatomyositis (JDM) is an autoimmune disease causing muscle weakness and skin rashes. Early diagnosis and treatment, including steroids and other immunosuppressants, improve patient outcomes and recovery rates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Juvenile idiopathic arthritis of the knee: is contrast needed to score disease activity when using an augmented MRI protocol comprising PD-weighted sequences?

European radiology·2022
Same author

[Travelling with rheumatic diseases].

Zeitschrift fur Rheumatologie·2021
Same author

Outcome of children with oligoarticular juvenile idiopathic arthritis compared to polyarthritis on methotrexate- data of the German BIKER registry.

Pediatric rheumatology online journal·2021
Same author

[Pain in rheumatic diseases].

Zeitschrift fur Rheumatologie·2021
Same author

[Active vaccinations : One of the essential measures to maintain the health of our patients with rheumatic diseases].

Zeitschrift fur Rheumatologie·2020
Same author

[Autoinflammatory diseases].

Zeitschrift fur Rheumatologie·2020

Area of Science:

  • Rheumatology
  • Pediatrics
  • Immunology

Context:

  • Juvenile dermatomyositis (JDM) is a rare inflammatory disease affecting children.
  • It involves characteristic skin rashes and progressive muscle weakness.
  • The exact cause of JDM remains unknown.

Purpose:

  • To provide a comprehensive overview of Juvenile Dermatomyositis (JDM).
  • To detail diagnostic criteria and current treatment strategies.
  • To discuss the prognosis and potential long-term outcomes for affected children.

Summary:

  • JDM presents with skin manifestations like heliotrope rash and Gottron's sign, alongside proximal muscle weakness.
  • Diagnosis relies on clinical signs, elevated muscle enzymes, and investigations like EMG, muscle biopsy, and MRI.
  • Treatment typically involves high-dose steroids, potentially combined with other immunosuppressants like methotrexate to mitigate side effects.

Impact:

  • Prognosis for JDM has significantly improved, with most patients achieving functional recovery.
  • However, some individuals may experience severe complications such as muscle atrophy or calcinosis.
  • Ongoing research aims to further refine treatments and improve long-term outcomes for JDM patients.

Related Experiment Videos